Leidos Holdings reaches a 20-day high amid market weakness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 08 Jan 26
Source: Benzinga
Leidos Holdings Inc. saw a price increase of 3.49% as it reached a 20-day high. This movement occurred while the Nasdaq-100 and S&P 500 indices were down 0.47% and 0.10%, respectively.
The stock's rise is attributed to sector rotation, as investors are shifting their focus towards companies like Leidos Holdings amid broader market weakness. The positive price action indicates a potential realignment of investor interest towards sectors that are performing better despite the overall market decline.
This upward movement could signal a growing confidence in Leidos Holdings' business model and future prospects, especially as investors look for stability in uncertain market conditions.
Analyst Views on LDOS
Wall Street analysts forecast LDOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LDOS is 219.70 USD with a low forecast of 178.00 USD and a high forecast of 235.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
7 Buy
4 Hold
0 Sell
Moderate Buy
Current: 189.500
Low
178.00
Averages
219.70
High
235.00
Current: 189.500
Low
178.00
Averages
219.70
High
235.00
About LDOS
Leidos Holdings, Inc. is a holding company, which operates through its wholly owned subsidiary, Leidos, Inc. (Leidos). The Company’s segments include National Security & Digital, Health & Civil, Commercial & International and Defense Systems. Its National Security & Digital business provides technologically advanced services, solutions and products, as well as mission software capabilities for defense and intelligence customers in the areas of cyber, logistics, security operations and decision analytics. Its Health & Civil business provides services and solutions to federal and commercial customers in the areas of public health, care coordination, life and environmental sciences and transportation. Its Commercial & International business delivers a portfolio of products, services, and solutions aimed at securing national assets, modernizing energy and critical infrastructure, and enhancing mission outcomes. The Company serves government and commercial customers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
